Zydus Lifesciences Ltd: Guardant360, a non-invasive portfolio of liquid and tissue biopsy test, conducts a comprehensive genetic profiling of solid tumors by examining circulating tumor DNA (ctDNA) obtained from a simple blood sample.
China Matters Feature: How is Dongguan changing manufacturing with 3D printing? - PRN India News webindia123.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webindia123.com Daily Mail and Mail on Sunday newspapers.
- These new Codes are required to access Medicare/Medicaid insurance Reimbursement for novel CELLSEARCH Circulating Multiple Myeloma Cell (CMMC) and HER2 .